Europe
Abacus Medicine Pharma Services (‘Abacus’) announces the signing of a partnership agreement with Mirum Pharmaceuticals, Inc. (‘Mirum...
September 11, 2024 | News
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck® test in Europe&...
September 10, 2024 | News
The Diagnostics & Research Institute for Pathology at the Medical University of Graz, a leader in personalized patient care and one of the largest hosp...
September 09, 2024 | News
New Pharmaceutical Auxiliary Materials cGMP standard introduced for cell culture media manufacturing Merck first in the industry to receive EXCiPACT&nbs...
September 06, 2024 | News
Antabio, a private biopharmaceutical company developing novel and highly differentiated antibacterial treatments for critical priority pathogens, with a pa...
September 06, 2024 | News
Crucial Data Solutions, a leading provider of data collection and trial management software to advance clinical research, has announced the launch of...
September 06, 2024 | News
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry The company serves blue-chip clients in Europe TTP Gr...
September 06, 2024 | News
Aptamer is working with Unilever to develop Optimer binders as novel active ingredients in deodorants that target the enzyme that causes sweat to smell, ai...
September 04, 2024 | News
Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and a subsidiary of Biocon Ltd , announced that the Company has signed a settleme...
August 29, 2024 | News
The Alzheimer's Association welcomes decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqem...
August 23, 2024 | News
Finnish biotech company NADMED has developed the first test to measure all four bodily forms of vitamin B3, called NADs, and glutathiones directly from fre...
August 23, 2024 | News
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
AbbVie announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy fo...
August 20, 2024 | News
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval ...
July 29, 2024 | News
Most Read
Bio Jobs
News